Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 4, 2017, Pages

  Colli, Agostino ^a   Gana, Juan Cristóbal ^b   Yap, Jason ^c   Adams Webber, Thomasin ^d   Rashkovan, Natalie ^e   Ling, Simon C ^d   Casazza, Giovanni ^f  

^a A MANZONI HOSPITAL   (Italy)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD CELL RATIO; CHRONIC LIVER DISEASE; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; MEDLINE; META ANALYSIS; PLATELET COUNT TO SPLEEN LENGTH RATIO; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SPLEEN LENGTH; SPLEEN SIZE; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; ADULT; ANATOMY AND HISTOLOGY; BLOOD; CHILD; CHRONIC DISEASE; CHRONIC HEPATITIS C; COMPLICATION; DUODENOSCOPY; EMERGENCY HEALTH SERVICE; ESOPHAGEAL AND GASTRIC VARICES; HEPATIC PORTAL VEIN; LIVER DISEASE; ORGAN SIZE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPLEEN; VEIN THROMBOSIS;

ADULT; CHILD; CHRONIC DISEASE; DUODENOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES; ORGAN SIZE; PLATELET COUNT; PORTAL VEIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; SPLEEN; TRIAGE; VENOUS THROMBOSIS;

EID: 85018338134     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008759.pub2     Document Type: Review

References (178)

1. Abd-Elsalam S, Habba E, Elkhalawany W, Tawfeek S, Elbatea H, El-Kalla F, et al. Correlation of platelet count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis. Medicine (Baltimore) 2016;95:e3853. 5462370
2. Habba E, Abd-Elsalam S, Ibrahim S, Dwidar A. Correlation of platelet count with endoscopic findings in Egyptian patients with liver cirrhosis. Hepatology International 2016;10:S365. 5462371
3. Abu El Makarem MA, Shatat ME, Shaker Y, Abdel Aleem AA, El Sherif AM, Moaty MA, et al. Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: the special Egyptian situation. Hepatitis Monthly 2011;11(4):278-84. 5462373
4. Adami MR, Ferreira CT, Kieling CO, Hirakata V, Vieira SMG. Noninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertension. World Journal of Gastroenterology 2013;19(13):2053-9. 5462375
5. Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Digestive Diseases and Sciences 2009;54(3):654-60. [PUBMED: 18594972]5462377
6. Agha A, Abdulhadi MM, Marenco S, Bella A, Alsaudi D, El Haddad A, et al. Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi Journal of Gastroenterology 2011;17(5):307-11. 5462379
7. Alcantara RV, Yamada RM, De Tommaso A, Bellomo-Brandão MA, Hessel G. Non-invasive predictors of esophageal varices in children and adolescents with chronic liver disease or extrahepatic portal venous obstruction. Jornal de Pediatria 2012;88(4):341-6. 5462381
8. Amin K, Muhammad D, Anjum A, Jamil K, Hassan A. Platelet count to spleen diameter ratio as a predictor of esophageal varices in patients of liver cirrhosis due to hepatitis C virus. Journal of University Medical Dental College 2012;3:6-11. 5462383
9. Aqodad N, Ighoudane H, Elyousfi M, Mellouki I, Elabkari M, Benajeh D, et al. Correlation of platelet count with grading of esophageal varices in cirrhotic patients. Hepatology International 2011;5(1):362. 5462385
10. Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: is it feasible?. Canadian Journal of Gastroenterology 2008;22(10):825-8. 5462387
11. Barikbin R, Hekmatnia A, Omidifar N, Farghadani M, Adibi P. Prediction severity of esophageal varices: a new cutoff point for platelet count/spleen diameter ratio. Minerva Gastroenterologica e Dietologica 2010;56(1):1-6. 5462389
12. Burton JR Jr, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. Journal of Clinical Gastroenterology 2007;41(6):609-15. 5462391
13. Burton JR Jr, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. Journal of Clinical Gastroenterology 2007;41(6):609-15. 5462393
14. Burton JR Jr, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. Journal of Clinical Gastroenterology 2007;41(6):609-15. 5462395
15. Burton JR Jr, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. Journal of Clinical Gastroenterology 2007;41(6):609-15. 5462397
16. Camma C, Petta S, Di Marco V, Bronte F, Ciminnisi S, Licata G, et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology (Baltimore, Md) 2009;49(1):195-203. [PUBMED: 19065558]5462399
17. Castera L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of Hepatology 2009;50(1):59-68. 5462401
18. Cherian JV, Deepak N, Ponnusamy RP, Somasundaram A, Jayanthi V. Non-invasive predictors of esophageal varices. Saudi Journal of Gastroenterology 2011;17(1):64-8. 5462403
19. Chiodi D, Hernandez N, Saona G, Sanchez A, Berrueta J, Mescia G, et al. [Noninvasive diagnosis of esophageal varices in cirrhotic patients] [Spanish]. Acta Gastroenterologica Latinoamericana 2014;44(2):108-13. 5462405
20. Colecchia A, Di Biase AR, Scaioli E, Predieri B, Iughetti L, Reggiani MLB, et al. Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. Digestive and Liver Disease 2011;43(8):659-63. 5462407
21. Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 2012;143(3):646-54. 5462409
22. De Mattos AZ, De Mattos AA, Vianna FF, Musskopf MI, Pereira-Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arquivos de Gastroenterologia 2010;47(3):275-8. 5462411
23. Ding NS, Nguyen T, Iser DM, Hong T, Flanagan E, Wong A, et al. Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices. Liver International 2016;36(2):240-5. [CRS: 6800131000104399; EMBASE: 20151018144]5462413
24. Ditchfield MR, Gibson RN, Donlan JD, Gibson PR. Duplex Doppler ultrasound signs of portal hypertension: relative diagnostic value of examination of paraumbilical vein, portal vein and spleen. Australasian Radiology 1992;36(2):102-5. [PUBMED: 1520164]5462415
25. Abu El Makarem MA, Shatat ME, Shaker Y, Abdel Aleem AA, El Sherif AM, Moaty MA, et al. Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: the special Egyptian situation. Hepatitis Monthly 2011;11:278-84. 5462417
26. El Ray A, Azab MM, El-Aziz IM, El-Aleem AA, El-Talkawy MD, El-Badea MA, et al. Non-invasive predictors for the presence, grade and risk of bleeding from esophageal varices in patients with post-hepatic cirrhosis. Journal of the Egyptian Society of Parasitology 2015;45:421-8. 5462419
27. Esmat S, Omarn D, Rashid L. Can we consider the right hepatic lobe size/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients?. European Journal of Internal Medicine 2012;23(3):267-72. 5462421
28. Gana JC, Turner D, Mieli-Vergani G, Davenport M, Miloh T, Avitzur Y, et al. A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology 2011;141(6):2009-16. 5462423
29. Gentile I, Viola C, Graf M, Liuzzi R, Quarto M, Cerini R. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. Journal of Clinical Gastroenterology 2009;43(1):81-7. 5462425
30. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52(8):1200-5. [PUBMED: 12865282]5462427
31. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52(8):1200-5. [PUBMED: 12865282]5462429
32. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Digestive and Liver Disease 2005;37(10):779-85. [PUBMED: 15996912]5462431
33. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. American Journal of Gastroenterology 2006;101(11):2511-9. [PUBMED: 17029607]5462433
34. Gonzalez-Ojeda A, Cervantes-Guevara G, Chavez-Sanchez M, Davalos-Cobian C, Ornelas-Cazares S, Macias-Amezcua MD, et al. Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. World Journal of Gastroenterology 2014;20(8):2079-84. 5462435
35. Grgurevic I, Jukic I, Sokol S, Banic M, Bilic B, Gunjaca I, et al. Low specificity of platelet to spleen ratio for noninvasive prediction and characterization of esophageal varices in patients with alcoholic liver cirrhosis [Omjer broja trombocita i velicine slezene ima nisku specificnost u neinvazivnoj predikciji i karakterizaciji varikoziteta jednjaka kod bolesnika s alkoholnom cirozom jetre]. Acta Medica Croatica 2014;68(4-5):353-60. [CRS: 6800131000062413; EMBASE: 2015400928; JC--NLM: Journal ID:bh2, 9208249; PUBMED: 26285468]5462437
36. Jeon SW, Cho CM, Tak WY, Ryeom HK, Kweon YO, Kim SK, et al. The value of Doppler-ultrasonography and laboratory tests as non-invasive predictors of the presence of esophageal varices in patients with chronic liver disease. Korean Journal of Gastroenterology 2006;48(3):180-7. [PUBMED: 17047433]5462439
37. Karatzas A, Triantos C, Kalafateli M, Marzigie M, Labropoulou-Karatza C, Thomopoulos K, et al. Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices. Annals of Gastroenterology 2016;29(1):71-8. [CRS: 6800131000104406; EMBASE: 20160031721]5462441
38. Legasto JMA, Sevilla J, Balay A, Tan JA, Cham LV, Vitug A, et al. Platelet count/spleen diameter ratio: a noninvasive parameter to predict the presence of esophageal varices. Philippine Journal of Gastroenterology 2006;2:33-8. 5462443
39. Lei JB, Huang TZ. Value of the platelet count/spleen diameter ratio on predicting esophageal varices of liver cirrhosis. Practical Clinical Medicine 2007;8:25-7. 5462445
40. Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G, et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clinical Gastroenterology and Hepatology 2007;5(7):803-8. [PUBMED: 17544879]5462447
41. Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G, et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clinical Gastroenterology and Hepatology 2007;5(7):803-8. [PUBMED: 17544879]5462449
42. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. Journal of Clinical Gastroenterology 2002;34(1):81-5. [PUBMED: 11743252]5462451
43. Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio E, Kissi HY, et al. Usefulness of noninvasive predictors of oesophageal varices in black African cirrhotic patients in Cote d'Ivoire (West Africa). Gastroenterology Research and Practice 2012;2012:(no pagination). [CRS: 6800131000104543; EMBASE: 2012476143]5462453
44. Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio E, Kissi HY, et al. Usefulness of noninvasive predictors of oesophageal varices in black African cirrhotic patients in Cote d'Ivoire (West Africa). Gastroenterology Research and Practice 2012;2012:(no pagination). [CRS: 6800131000104543; EMBASE: 2012476143]5462455
45. Mosqueira JR, Montiel JB, Rodriguez D, Monge E. Evaluation of the diagnostic test of index platelet counts/size spleen, as a predictor of the presence of esophageal varices in cirrhosis [Spanish]. Revista de Gastroenterologia del Peru 2011;31(1):11-6. 5462457
46. Parrino A, Di Gesaro V, Terranova A, Sesti R, Corsale S, Patti AM, et al. Non-invasive diagnosis of esophageal varices in cirrhotic patients: endoscopic vs ultrasonographic findings [Italian]. Acta Medica Mediterranea 2008;24(1):11-8. 5462459
47. Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. Journal of Hepatology 1999;31(5):867-73. [PUBMED: 10580584]5462461
48. Prihatini J, Lesmana LA, Manan C, Gani RA. Detection of esophageal varices in liver cirrhosis using non-invasive parameters. Acta Medica Indonesiana 2005;37(3):126-31. [PUBMED: 16110174]5462463
49. Primignani M, Savojardo V, Dell'Era A, Fazzini L, Zatelli S, Pedotti P, et al. Presence of esophageal varices in patients with a recent histologic diagnosis of cirrhosis of the liver: evaluation of clinical predictors. Gastroenterology 2002; Vol. 122, issue Suppl 4:A354. 5462465
50. Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointestinal Endoscopy 2006;64(6):855-64. [PUBMED: 17140886]5462467
51. Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi Journal of Gastroenterology 2010;16(1):38-42. 5462469
52. Schwarzenberger E, Meyer T, Golla V, Sahdala NP, Min AD. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. Journal of Clinical Gastroenterology 2010;44(2):146-50. 5462471
53. Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. Journal of Hepatology 2010;53(4):630-8. 5462473
54. Sen S, Griffiths WJH. Non-invasive prediction of oesophageal varices in cirrhosis. World Journal of Gastroenterology 2008;14:2454-5. 5462475
55. Sen S, Griffiths WJH. Non-invasive prediction of oesophageal varices in cirrhosis. World Journal of Gastroenterology 2008;14:2454-5. 5462477
56. Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, et al. Spleen stiffness in patients with cirrhosis in predicting esophageal varices. American Journal of Gastroenterology 2013;108(7):1101-7. 5462479
57. Sharma J, Yadav MK, Gupta A, Arya TS. A study of role of platelet count/spleen diameter ratio as a predictor of esophageal varices in patient with chronic liver disease. National Journal of Medical Research 2014;4(3):232-4. 5462481
58. Sharma J, Yadav MK, Gupta A, Arya TS. A study of the role of platelet count/spleen diameter ratio as a predictor of esophageal varices in patients with chronic liver disease. Indian Journal of Gastroenterology 2012;31(1 Suppl):A136-7. 5462482
59. Abd-Elsalam SM, Sheta EA, Yousef M, Mohamed REE, Amer I, Ismail A. Non invasive diagnosis of esophageal varices: can it replace screening endoscopy?. Hepatology International 2016;10(1 Suppl):S496. [CRS: 6800131000104388; EMBASE: 72201392]5462484
60. Sheta EAE, Yousef M, Abd-Elsalam S, Mohamed REE, Ismail A, El-Kalla F, et al. Non invasive diagnosis of esophageal varices: can it replace screening endoscopy?. International Journal of Current Microbiology and Applied Sciences 2016;5:701-16. 5462485
61. Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. Journal of Gastroenterology and Hepatology 2011;26:164-70. 5462487
62. Tafarel JR, Tolentino LHL, Correa LM, Bonilha DR, Piauilino P, Martins FP, et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. European Journal of Gastroenterology & Hepatology 2011;23(9):754-8. 5462489
63. Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Toshikuni N, et al. Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology 2013;144(1):92-101. 5462491
64. Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A, Milan G, et al. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterology 2009;9:21. [PUBMED: 19292923]5462493
65. Wadhva R, Abbas Z, Luck NH, Hassan SM, Abubakr M. Platelet count to splenic diameter ratio and splenoportal index for predicting esophageal varices among patients with cirrhosis. Hepatology International 2012;6(1):294. 5462495
66. Wang C-C, Tsai M-C, Yang T-W, Lin C-B, Chen T-Y, Lin C-C. Acoustic radiation force impulse sonography-based non-invasive prediction of esophageal varices. Journal of Gastroenterology and Hepatology 2015;30(Suppl S4):367-8. [CRS: 6800131000104411; EMBASE: 72135359]5462497
67. Wang H-M, Lo G-H, Chen W-C, Hsu P-I, Yu H-C, Lin C-K, et al. Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis. Journal of Digestive Diseases 2012;13(8):430-8. 5462499
68. Wang J-H, Chuah S-K, Lu S-N, Hung C-H, Chen C-H, Kee K-M. Transient elastography and simple blood markers in diagnosis of oesophageal varices for compensated patients with hepatitis B virus-related cirrhosis. Hepatology International 2012;6(1):6. 5462501
69. Xu X-D, Xu C-F, Dai J-J, Qian J-Q, Pin X. Ratio of platelet count/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis. European Journal of Gastroenterology & Hepatology 2016;28(5):588-91. [CRS: 6800131000104363; EMBASE: 20160122451]5462503
70. Zafar S, Latif MM. Diagnostic accuracy of platelet count/spleen diameter ratio for detection of esophageal varices in cirrhotic patients taking endoscopy as gold standard. Pakistan Journal of Medical and Health Sciences 2014;8(4):951-4. 5462505
71. Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Archives of Internal Medicine 2001;161(21):2564-70. 5462507
72. Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology (Baltimore, Md) 2004;39(1):204-10. [PUBMED: 14752839]5462509
73. Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology (Baltimore, Md) 2004;39(1):204-10. [PUBMED: 14752839]5462511
74. Zimbwa TA, Blanshard C, Subramaniam A. Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut 2004; Vol. 53, issue 7:1055. [PUBMED: 15194662]5462513
75. Albreedy AM. Platelet count to spleen diameter ratio and to spleen area ratio as predictors for esophageal varices in chronic hepatitis C patients with liver cirrhosis. Journal of the Egyptian Society of Parasitology 2015;45:485-92. 5462515
76. Amarapurkar DN, Parikh SS, Shankaran K, Chopra K, Dhawan P, Kalro RH, et al. Correlation between splenomegaly and oesophageal varices in patients with liver cirrhosis. Endoscopy 1994; Vol. 26, issue 6:563. [PUBMED: 7828573]5462517
77. Barrera F, Riquelme A, Soza A, Contreras A, Barrios G, Padilla O, et al. Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Annals of Hepatology 2009;8(4):325-30. 5462519
78. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. American Journal of Gastroenterology 1999;94(11):3285-91. [PUBMED: 10566731]5462521
79. Cho EJ, Kim MY, Lee JH, Lee IY, Lim YL, Choi DH, et al. Diagnostic and prognostic values of noninvasive predictors of portal hypertension in patients with alcoholic cirrhosis. PloS One 2015;10(7):e0133935. [CRS: 6800131000104272; JC--NLM: Journal ID:101285081; OI:SOURCE:: NLM. PMC4511411; PUBMED: 26196942]5462523
80. El Guindi M, El Arabi H, El Henawy I, Basiouny H. Non-invasive parameters as predictors for esophageal varices in children with chronic liver disease. Hepatology (Baltimore, Md) 2008; Vol. 48, issue 4 Suppl:1040A. 5462525
81. El Sherif AM, Abou-Shady MA, Al Bahrawy AM, Bakr RM, Hosny A. Nitric oxide levels in chronic liver disease patients with and without oesophageal varices. Hepatology International 2008;2:341-5. 5462527
82. Fagundes ED, Ferreira AR, Roquete ML, Penna FJ, Goulart EM, Figueiredo Filho PP, et al. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome. Journal of Pediatric Gastroenterology and Nutrition 2008;46(2):178-83. [PUBMED: 18223377]5462529
83. Gana JC, Turner D, Roberts EA, Ling SC. Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children. Journal of Pediatric Gastroenterology and Nutrition 2010;50:188-93. 5462531
84. Giannini EG, Anwar E, Bashir K, Savarino V, Agha A. Platelet count/spleen diameter ratio and AASLD criterion for screening esophageal varices in patients with hepatitis C virus related compensated cirrhosis. Hepatology (Baltimore, Md) 2007; Vol. 46, issue 4 Suppl 1:568A. 5462533
85. Hong WD, Zhu QH, Huang ZM, Chen XR, Jiang ZC, Xu SH, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterology 2009;9:11. [PUBMED: 19196464]5462535
86. Koncoro H, Mariadi K, Somayana G, Suryadarma GA, Purwadi N, Wibawa DN. Prediction of large esophageal varices among patients with liver cirrhosis in Sanglah Hospital Danpasar. Journal of Gastroenterology and Hepatology 2014;29(Suppl S3):193. 5462537
87. Lee JH, Yoon JH, Lee CH, Myung SJ, Keam B, Kim BH, et al. Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients. Journal of Viral Hepatitis 2009;16(6):444-52. [PUBMED: 19200133]5462539
88. Malik K, Batool F, Khan SA, ul Amir Z. Platelet count/splenic size ratio as a non-invasive parameter to predict the presence of esophageal varices in cirrhotics. Rawal Medical Journal 2015;40(4):371-4. [CRS: 6800131000063484; EMBASE: 2015504984]5462541
89. Nashaat EH, Abd-Elaziz H, Sabry M, Ibrahim AA. Non-endoscopic predictors of esophageal varices and portal hypertensive gastropathy. Nature and Science 2010;8:43-50. 5462543
90. Nazish Z, Inayatullah M, Tanweer S. Non endoscopic predictors of esophageal varices in cirrhotics. Medical Forum Monthly 2011;22:3-7. 5462545
91. Ng FH, Wong SY, Loo CK, Lam KM, Lai CW, Cheng CS. Prediction of oesophagogastric varices in patients with liver cirrhosis. Journal of Gastroenterology and Hepatology 1999;14(8):785-90. [PUBMED: 10482429]5462547
92. Park Y, Kim SU, Park SY, Kim BK, Park JY, Kim DY, et al. A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One 2015;10(3):e0121009. 5462549
93. Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (Baltimore, Md) 2008;47:153-9. 5462551
94. Rockey DC, Elliott A, Lyles T. Prediction of esophageal varices and variceal hemorrhage in patients with acute upper gastrointestinal bleeding. Journal of Investigative Medicine 2016;64(3):745-51. [CRS: 6800131000104572]5462553
95. Sebastiani G, Albert A, Castera l, Halfon P, Bourliere M, Angeli P, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple non invasive markers: results of a multicenter, international study. Hepatology (Baltimore, Md) 2008; Vol. 48, issue 4 Suppl:624A. 5462555
96. Sethar GH, Ahmed R, Rathi SK, Shaikh NA. Platelet count/splenic size ratio: a parameter to predict the presence of esophageal varices in cirrhotics. Journal of the College of Physicians and Surgeons - Pakistan 2006;16(3):183-6. [PUBMED: 16542615]5462557
97. Shah ZH, Sarwar S, Saleem K, Abaidullah S, Mehboob F, Afzal A. Identification of non-endoscopic predictors of esophageal varices in cirrhosis. Pakistan Journal of Medical and Health Sciences 2011;5:257-61. 5462559
98. Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. Journal of Gastroenterology and Hepatology 2007;22(11):1909-15. [PUBMED: 17914969]5462561
99. Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Takabatake H, et al. Portal hypertension in patients with liver cirrhosis: diagnostic accuracy of spleen stiffness. Radiology 2016;279(2):609-19. [CRS: 6800131000104355; EMBASE: 20160357558]5462563
100. Tao W, Yang SQ, Lv XC, Yang L. Value of the platelet count/spleen diameter ratio on diagnosis of esophageal varices in patients with cirrhosis. Journal of Ningxia Medical College 2008;30:349-50. 5462565
101. Thayumanavan L, Jaisankar P, Ramani R, Kannan M, Sangumani J, Sreeraj V. Validating the usefulness of doppler study of hepatic veins in predicting esophageal varices in cirrhotic patients. Journal of Clinical and Experimental Hepatology 2012;2(1 Suppl):S19. 5462567
102. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Digestive and Liver Disease 2003;35(7):473-8. [PUBMED: 12870732]5462569
103. Treeprasertsuk S, Kowdley KV, Luketic VAC, Harrison ME, Mccashland T, Befeler AS. The predictors of the presence of varices in patients with primary sclerosing cholangitis. Hepatology (Baltimore, Md) 2010;51:1302-10. 5462571
104. Valente Pinto M, Castanhinha S, Pereira L, Lopes AI, Barreto C. Liver disease in children with cystic fibrosis - The contribution of ultrasound evaluation. Journal of Cystic Fibrosis 2013;12(Suppl 1):S112. 5462573
105. Yu JY, Liu XN, Wang D, Cui JJ. Non-invasive predictive factors of esophageal varices in patients with post-hepatitis B cirrhosis. Journal of Binzhou Medical University 2008;31:345-9. 5462575
106. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. American Journal of Gastroenterology 1999;94(11):3292-6. [PUBMED: 10566732]5462577
107. Zhang J, Tao R, You Z, Dai Y, Fan Y, Cui J, et al. Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PloS One 2013;8(1):e55626. [CRS: 6800131000104538; EMBASE: 2013079030]5462579
108. Zhang C-X, Xu J-M, Li J-B, Kong D-R, Wang L, Xu X-Y, et al. Predict esophageal varices via routine trans-abdominal ultrasound: a design of classification analysis model. Journal of Gastroenterology and Hepatology (Australia) 2016;31(1):194-9. [CRS: 6800131000104397; EMBASE: 20160106034]5462581
109. Abraldes JG, Bureau C, Stefanescu H, Augustin S, Ney M, Blasco H, et al. Non-invasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the "Anticipate" study. Hepatology 2016 Sep 17 [Epub ahead of print]. [DOI: 10.1002/hep.28824]
110. Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, et al. Screening in liver disease: report of an AASLD clinical workshop. Hepatology (Baltimore, Md) 2004;39(5):1204-12. [PUBMED: 15122748]
111. Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. American Journal of Gastroenterology 2002;97(9):2441-52. [PUBMED: 12358270]
112. ASGE Standards of Practice Committee, Ben-Menachem T, Decker GA, Early DS, Evans J, Fanelli RD, Fisher DA, et al. Adverse events of upper GI endoscopy. Gastrointestinal Endoscopy 2012;76:707-18.
113. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008;57(6):814-20. [PUBMED: 18250126]
114. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology (Baltimore, Md) 1994;20(6):1442-9. [PUBMED: 7982643]
115. Bendtsen F, Skovgaard LT, Sorensen TI, Matzen P. Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding. Hepatology (Baltimore, Md) 1990;11(3):341-7. [PUBMED: 2312048]
116. Cales P, Buscail L, Bretagne JF, Champigneulle B, Bourbon P, Duclos B, et al. Interobserver and intercenter agreement of gastro-esophageal endoscopic signs in cirrhosis. Results of a prospective multicenter study [Concordance inter-observateurs inter-centres des signes endoscopiques gastro-oesophagiens au cours de la cirrhose. Resultats d'une etude prospective multicentrique]. Gastroenterologie Clinique et Biologique 1989;13(12):967-73. [PUBMED: 2696663]
117. Cales P, Desmorat H, Vinel JP, Caucanas JP, Ravaud A, Gerin P, et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 1990;31(11):1298-302. [PUBMED: 2253916]
118. Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. European Journal of Gastroenterology and Hepatology 2012;24:431-6.
119. Colli A, Fraquelli M, Casazza G, Conte D, Nikolova D, Duca P, et al. The architecture of diagnostic research: from bench to bedside - research guidelines using liver stiffness as an example. Hepatology (Baltimore, Md) 2014;60:408-18. [DOI: 10.1002/hep.26948]
120. Colli A, Gana JC, Turner D, Yap J, Adams-Webber T, Ling SC, et al. Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD008760.pub2]
121. Cotton PB, Hawes RH, Barkun A, Ginsberg GG, Amman S, Cohen J, et al. Excellence in endoscopy: toward practical metrics. Gastrointestinal Endoscopy 2006;63:286-91.
122. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminars in Liver Disease 1999;19(4):475-505. [PUBMED: 10643630]
123. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology (Baltimore, Md) 2003;38(3):599-612. [PUBMED: 12939586]
124. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131(5):1611-24. [PUBMED: 17101332]
125. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology 2006;44:217-31.
126. D'Amico G, Pasta L, Morabito A, D'Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Alimentary Pharmacology & Therapeutics 2014;39:1180-93.
127. de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. Journal of Hepatology 1992;15(1-2):256-61. [PUBMED: 1506645]
128. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology 2010;53(4):762-8. [PUBMED: 20638742]
129. de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. Journal of Hepatology 2015;63:743-52.
130. Diagnostic Test Accuracy Working Group. Handbook for DTA Reviews. srdta.cochrane.org/handbook-dta-reviews 2010 (accessed 23 September 2016).
131. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. Journal of Hepatology 2011;55:245-64.
132. Gana JC, Turner D, Yap J, Adams-Webber T, Rashkovan N, Ling SC. Magnetic resonance imaging, computer tomography scan, and oesophagography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008763]
133. Gana JC, Turner D, Yap J, Adams-Webber T, Rashkovan N, Ling SC. Transient ultrasound elastography and magnetic resonance elastography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008761]
134. Gana JC, Turner D, Yap J, Adams-Webber T, Rashkovan N, Ling SC. Non-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008764]
135. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology 2007;102(9):2086-102. [PUBMED: 17727436]
136. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding - unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology (Baltimore, Md) 2008; Vol. 47, issue 5:1764-72. [PUBMED: 18435460]
137. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2017;65:310-35.
138. Geraci G, Pisello F, Modica G, Li Volsi F, Arnone E, Sciumè C. Complications of elective esophago-gastro-duodenoscopy (EGDS). Personal experience and literature review. Il Giornale di Chirurgia 2009;30:502-6.
139. Gluud LL, Klingenberg S, Nikolova D, Gluud C. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. American Journal of Gastroenterology 2007;102(12):2842-8; quiz 2841, 2849. [PUBMED: 18042114]
140. Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. CochraneDatabase of Systematic Reviews 2012;Issue 8:CD004544.
141. Gluud C, Nikolova D, Klingenberg SL. Cochrane Hepato-Biliary Group. About Cochrane (Cochrane Review Groups (CRGs)) 2016, Issue 8. Art. No.: LIVER.
142. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (Baltimore, Md) 1998; Vol. 28, issue 3:868-80. [PUBMED: 9731585]
143. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80(4):800-9. [PUBMED: 6970703]
144. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. New England Journal of Medicine 2005;353(21):2254-61. [PUBMED: 16306522]
145. Grover SA, Barkun AN, Sackett DL. Does this patient have splenomegaly?. JAMA 1993;270:2218-21.
146. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology (Baltimore, Md) 2001;33(4):802-7. [PUBMED: 11283842]
147. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000;46(Suppl 3-4):III1-III15. [PUBMED: 10862604]
148. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002;122(6):1620-30. [PUBMED: 12016427]
149. Japanese Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Japanese Journal of Surgery 1980;10(1):84-7.
150. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md) 2001;33(2):464-70. [PUBMED: 11172350]
151. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79(6):1139-44. [PUBMED: 6969201]
152. Leffler DA, Kheraj R, Garud S, Neeman N, Nathanson LA, Kelly CP, et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Archives of Internal Medicine 2010;170:1752-7.
153. Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis. American Journal of the Medical Sciences 2003;326(3):111-6. [PUBMED: 14501224]
154. McDiarmid SV, Anand R, Lindblad AS. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74(2):173-81. [PUBMED: 12151728]
155. Megremis SD, Vlachonikolis IG, Tsilimigaki AM. Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters. Radiology 2004;231:129-34.
156. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. Journal of Hepatology 2003;38(3):266-72. [PUBMED: 12586291]
157. National Institute for Health and Clinical Excellence (NICE). Cirrhosis in over 16s. Assessment and management. NICE guideline NG50. Methods, evidence and recommendations. National Institute for Health and Care Excellence, 2016.
158. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. New England Journal of Medicine 1988;319(15):983-9. [PUBMED: 3262200]
159. Pagliaro L, Spina GP, D'Amico G, Brocchi E, Caletti G, Cosentino F, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Journal of Hepatology 1987;4:93-8.
160. Pagliaro L, D'Amico G, Sorenson TIA, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized clinical trials of nonsurgical treatment. Annals of Internal Medicine 1992;117:59-70.
161. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Canadian Journal of Gastroenterology 2000;14(Suppl D):60D-6D. [PUBMED: 11110614]
162. Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Alimentary Pharmacology & Therapeutics 2007;26(Suppl 1):21-8. [PUBMED: 17958516]
163. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. American Journal of Gastroenterology 2002;97(8):2040-5. [PUBMED: 12190174]
164. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery 1973;60(8):646-9. [PUBMED: 4541913]
165. Quinn PG, Johnston DE. Detection of chronic liver disease: costs and benefits. Gastroenterologist 1997;5(1):58-77. [PUBMED: 9074920]
166. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
167. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20(19):2865-84. [PUBMED: 11568945]
168. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. American Journal of Gastroenterology 2003;98(4):763-70. [PUBMED: 12738453]
169. Sarin SK, Kumar A, Angus PV, Baijal SS, Chawla YK, Dhiman RK, et al. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatology International 2008;2:429-39.
170. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. New England Journal of Medicine 2001;345(9):669-81. [PUBMED: 11547722]
171. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA 1976;235:928-30.
172. Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective?. Hepatology (Baltimore, Md) 2003;37(2):366-77. [PUBMED: 12540787]
173. Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015;64:1680-704.
174. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
175. Winkfield B, Aube C, Burtin P, Cales P. Inter-observer and intra-observer variability in hepatology. European Journal of Gastroenterology & Hepatology 2003;15(9):959-66. [PUBMED: 12923367]
176. Wolfsen HC, Hemminger LL, Achem SR, Loeb DS, Stark ME, Bouras EP, et al. Complications of endoscopy of the upper gastrointestinal tract: a single-center experience. Mayo Clinic Proceedings 2004;79:1264-7.
177. Ying L, Lin X, Xie ZL, Hu YP, Shi KQ. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Digestive Diseases and Sciences 2012;57:1672-81.
178. Zoli M, Merkel C, Magalotti D, Marchesini G, Gatta A, Pisi E. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology (Baltimore, Md) 1996;24(5):1047-52. [PUBMED: 8903373]